Advertisement

UC’s top revenue-generating inventions

Share via

The University of California received more than $118 million in royalty and fee payments in 2014. Here are the top revenue-generating inventions:

Royalty and fee income (in thousands)

1. Prostate cancer drug, UCLA: $33,353

2. Hepatitis-B vaccine, UC San Francisco: $8,766

3. EGF receptor antibodies, UC San Diego: $6,754

4. Bovine growth hormone, UC San Francisco: $5,747

5. Chromosome painting, Lawrence Livermore National Laboratory: $3,571

Total royalty and fee income, 2014: $118,243

Source: University of California

Advertisement